Dyne Therapeutics
Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as a preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more at https://www.dyne-tx.com/ , and follow us on X , LinkedIn and Facebook .
Senior TMF Specialist
Director, US Marketing Operations
Senior Manager, U.S. Medical Affairs Operations
Senior Director, Portfolio Reporting & Analytics
Principal Scientist, Analytical Development
Senior Manager, Scientific and Medical Education
Associate Director, Oligonucleotide Development
Associate Director, Formulation and Drug Product Development
Senior Scientist, Process Development - Bioconjugation
Director, Regulatory CMC
Medical Science Liaison - West
Associate Director, Patient Advocacy and Operations
Senior Director, Program Management
Director, Business & Operations – US Commercial
Director, US Field Effectiveness & Operations
Associate Director, Trial Master File Lead
VP, Customer Experience
Senior Director, Scientific Communications Lead - DMD
Senior Director, Pricing & Reimbursement
Principal Engineer, Technical Development
Medical Director, US Medical Affairs
Executive Director, Regulatory Affairs Advertising & Promotion
Director, QA GMP Operations
Director of Training
Director, Imaging Biomarkers
Director, Global Health Economics & Outcomes Research (HEOR)
Director, Compliance
Director, Clinical Quality Assurance
Corporate Account Director - Optum/United Healthcare
Corporate Account Director - CVS/Aetna
Associate Director, Regulatory CMC
Associate Director, Commercial Insights and Analytics